LianBio (LIAN) News Today → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free LIAN Stock Alerts $0.32 0.00 (0.00%) (As of 05/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineWhy Is LianBio (LIAN) Stock Moving Today?investorplace.com - March 15 at 8:40 AMLianBio (NASDAQ:LIAN) Short Interest Down 33.5% in Februarymarketbeat.com - March 15 at 12:03 AMLianBio (NASDAQ:LIAN) Sets New 52-Week High at $4.98marketbeat.com - March 14 at 3:15 PMLianBio (NASDAQ:LIAN) Sets New 52-Week High at $4.96marketbeat.com - March 8 at 10:43 AMLianBio (NASDAQ:LIAN) Sets New 12-Month High at $4.88marketbeat.com - March 1 at 3:52 PMLianBio Announces Voluntarily Delisting from Nasdaqglobenewswire.com - February 28 at 7:00 AMWith No Cure In Sight, Drugs Firm LianBio Begins Exit Strategyseekingalpha.com - February 23 at 4:32 AMLianBio (NASDAQ:LIAN) Sees Strong Trading Volumemarketbeat.com - February 14 at 12:02 PMLianBio Announces Wind Down Of Operations, Workforce Reduction; Stock Up In Pre-Marketmarkets.businessinsider.com - February 13 at 1:49 PMLianBio (NASDAQ:LIAN) Sets New 52-Week High at $4.88marketbeat.com - February 13 at 11:28 AMLianBio to Wind Down Operations, Declares Special Dividendmarketwatch.com - February 13 at 8:49 AMLianBio Shares Gain After Co Announces Plans to Wind Downmarketwatch.com - February 13 at 8:49 AMLianBio Announces Completion of Strategic Reviewfinance.yahoo.com - February 13 at 8:49 AM131,641 Shares in LianBio (NASDAQ:LIAN) Acquired by Landscape Capital Management L.L.C.marketbeat.com - February 8 at 8:18 AMShort Interest in LianBio (NASDAQ:LIAN) Rises By 19.6%marketbeat.com - January 14 at 11:58 AMB of A Securities Downgrades LianBio: Here's What You Need To Knowmarkets.businessinsider.com - January 3 at 4:53 PMLianBio (NASDAQ:LIAN) Lowered to Underperform at Bank of Americamarketbeat.com - January 3 at 8:24 AMNanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Marketsmarkets.businessinsider.com - December 26 at 4:08 AMLianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Marketsfinance.yahoo.com - December 26 at 4:08 AMLianBio (NASDAQ:LIAN) Lowered to Hold at Jefferies Financial Groupmarketbeat.com - December 22 at 8:17 AMInterest Is Growing for Smaller, More Speculative Namesrealmoney.thestreet.com - December 20 at 3:33 PMLianBio Announces Departure of Chief Financial Officerfinance.yahoo.com - December 20 at 10:32 AMLianBio Names Stone as Interim CEO as Wang Resignsmarketwatch.com - December 19 at 6:16 PMLianBio Announces Departure of Chief Executive Officerfinance.yahoo.com - December 19 at 6:16 PMLianBio’s Board of Directors Unanimously Determines not to Pursue Unsolicited Proposal from Concentra Biosciencesfinance.yahoo.com - December 6 at 7:40 PMLianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciencesfinance.yahoo.com - December 1 at 8:48 PMLianBio (LIAN) Reports Q3 2023 Financial Results: Strategic Review in Progress Amid Clinical ...finance.yahoo.com - November 14 at 8:53 PMLianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 13 at 6:25 PMAll You Need to Know About LianBio Sponsored ADR (LIAN) Rating Upgrade to Strong Buyfinance.yahoo.com - November 8 at 6:06 PMLianBio Announces Topline Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitisfinance.yahoo.com - October 30 at 6:43 PMWhy LianBio Stock Is Shooting Through the Roof This Weekfool.com - October 27 at 9:04 AMLianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023finance.yahoo.com - October 25 at 6:39 PMRaymond James Maintains Outperform Rating for LianBio: Here's What You Need To Knowmarkets.businessinsider.com - October 25 at 1:38 PMLianBio Reaches Agreement With Bristol Myers Squibb For Mavacamten; Stock Upmarkets.businessinsider.com - October 24 at 10:38 AMLianBio Shares Soar Premarket on Strategic Review, End of Bristol Pactmarketwatch.com - October 24 at 10:38 AMWe're Not Very Worried About LianBio's (NASDAQ:LIAN) Cash Burn Ratefinance.yahoo.com - September 8 at 12:21 PMLianBio Announces Results from Phase 3 EXPLORER-CN Trial of Mavacamten Presented at the European Society of Cardiology Congress and Simultaneous Publication in JAMA Cardiologyfinance.yahoo.com - August 28 at 8:31 PMLianBio Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 14 at 6:40 PMLianBio Announces First Patient Treated in Phase 1 Trial of SHP2 Inhibitor BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR Mutationsfinance.yahoo.com - August 3 at 8:52 PMInstitutions own 21% of LianBio (NASDAQ:LIAN) shares but private equity firms control 54% of the companyfinance.yahoo.com - July 29 at 12:32 PMLianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitisfinance.yahoo.com - July 27 at 12:19 AMLianBio Partner NANOBIOTIX Enters into License Agreement with Janssen for Radioenhancer NBTXR3, with LianBio Retaining Development and Commercialization Rights in Greater China, South Korea, Singapore and Thailandfinance.yahoo.com - July 18 at 8:19 AMLianBio Announces Phase 3 EXPLORER-CN Data Accepted for Late-Breaking Presentation at the European Society of Cardiology Congress 2023finance.yahoo.com - July 17 at 10:14 AMLianBio Announces Clinical Supply Agreement with AstraZeneca in China to Evaluate BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR Mutationsfinance.yahoo.com - July 12 at 8:07 AMLianBio (NASDAQ:LIAN) Short Interest Up 193.4% in Junemarketbeat.com - June 30 at 8:43 AMLianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in Singaporefinance.yahoo.com - June 26 at 9:07 AM2 Stocks I'm Watching in a Market Supported by FOMO and Short Squeezesrealmoney.thestreet.com - June 12 at 5:00 PMLianBio Completes Enrollment in Pivotal Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitisfinance.yahoo.com - June 8 at 9:58 AMADRs End Mostly Lower, Oatly and LianBio Trade Activelymarketwatch.com - June 8 at 4:53 AMLianBio Announces Topline Results from Phase 2a Proof of Concept Trial Evaluating Infigratinib in Patients with Gastric Cancer & Receipt of Breakthrough Therapy Designation in Chinafinance.yahoo.com - June 6 at 4:50 PM Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Email Address The Department of Defense Has a New Drone Contractor (Ad)The Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes. Click here to see how to invest LIAN Media Mentions By Week LIAN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LIAN News Sentiment▼0.000.38▲Average Medical News Sentiment LIAN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LIAN Articles This Week▼01▲LIAN Articles Average Week Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EVAX News PHXM News AFMD News FGEN News OMGA News KNTE News NGM News ACXP News BCTX News VYNE News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LIAN) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressGold Set to EXPLODE!Gold Safe ExchangeThe AI Stock that’s Disrupting Every IndustryStockEarningsThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
